Hepatitis C Virus (HCV) Industry
Description
Wiseguyreports.Com Adds “Hepatitis C Virus (HCV) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database
Hepatitis C Virus (HCV) is an infection which affects the liver which may lead to serious consequences if not taken care of. It spreads through infected blood transfusions and poorly sterilized medical equipments. The number of patients has increased significantly because its symptoms take time to be recognized before the patient progresses towards a clinically visible liver damage which worsens the situation since it may lead to liver damage or even failure. There was no proper therapy for HCV before 2010 but the coming of therapies like Sovaldi and Harvoni by Gilead and Viekira Pak by AbbVie has improved the scenario. Also the steps taken like proper blood screening is also helping in identifying the patients.
The key factors which are anticipated to drive HCV market include medical reimbursement because of the therapy being very costly, growth in the number of patients, relatively smaller period of drug treatment from before, treatment of the warehoused patients who were waiting for a better therapy and pricing discounts and better regimens because of the increased competition. Some of the significant developments of this industry include launch of the interferon free regimen and development of products like Sovaldi, Harvoni and Viekira Pak and the newly identified and diagnosed patients. However, the challenges to be faced ahead is more number of patients asking for reimbursement, increasing competition leading to price cutting, risk associated with drug development and regulatory risk.
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/1615757-global-hepatitis-c-virus-hcv-market-report-2016-edition
This report offers a comprehensive analysis of the HCV market. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global HCV market is reined by few major players namely Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Table of Content
1. HCV Market
1.1 An Introduction
1.2 Types of Hepatitis C Virus
1.3 Ways of Spreading of HCV Infection
1.4 HCV Co Infections
1.5 Avoidance of HCV Infection
2. Global HCV Market
2.1 Global HCV Sales by Value
2.2 Global HCV Prevalence by Region
3. Global HCV Market by Region
3.1 The US Market
3.1.1 The US HCV Sales by Value
3.1.2 The US HCV Market Dynamics
3.1.3 HCV Patients Initiated Treatment with Sofosbuvir
3.2 European Union HCV Sales by Value
3.3 Japan HCV Sales by Value
3.4 ROW HCV Sales by Value
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Impact of Reimbursement
4.1.2 Growth in Number of Patients
4.1.3 Smaller Period of Drug Treatment
4.1.4 Improved Economic Growth
4.1.5 Increasing Healthcare Expenditure
4.1.6 Treatment of Warehoused Patients
4.1.7 Global Ageing Population
4.1.8 Pricing Discounts and Better Regimen
4.2 Trends and Development
4.2.1 Launch of Interferon Free Regimen and Development of New Products
4.2.1 Newly Identified and Diagnosed Patients
4.3 Challenges
4.3.1 Increase in Number of Patients for Reimbursement
4.3.2 Increased Competition leading to Price Cut
4.3.3 Risk Associated with Drug Development and Patent
4.3.4 Regulatory Risk
Leave a Query @ https://www.wiseguyreports.com/enquiry/1615757-global-hepatitis-c-virus-hcv-market-report-2016-edition
5. Competitive Landscape
5.1 Global Market
5.2 Global Product Sales
5.3 Viekira Vs. Harvoni – Current US Market Scenario
5.4 Viekira Vs. Harvoni – Future US Market Scenario
6. Company Profiles
6.1 Gilead Sciences
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 AbbVie
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Johnson & Johnson
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Bristol-Myers Squibb
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
7. Market Outlook
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1615757
Continued…
Contact Us: Sales@Wiseguyreports.com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
